News | June 08, 2026
Roche signs up to $2.3 billion deal with Nurix for BTK degrader Bexobrutideg
The agreement underscores Roche’s commitment to advancing innovative therapies for blood cancers and other serious diseases
The agreement underscores Roche’s commitment to advancing innovative therapies for blood cancers and other serious diseases
The program expected to commence in August 2026 will be offered across multiple specialised areas with an intake of 20-30 students per course
The webinar on World Environment Day brought together scientists, policymakers, industry representatives, and researchers to discuss the role of biotech and biomanufacturing in addressing climate change and advancing sustainable development
Amitabh Dube and Sheetal Arora named Co-Chairmen for the forthcoming term
The approved product is therapeutically equivalent to Haldol tablets of Ortho McNeil Pharmaceutical
The addition of the Halcyon system represents a significant milestone in the hospital’s oncology services
Rahul brings over 17 years of experience in human resources leadership across the healthcare, banking, information technology, and FMCG sectors
The company recycled approximately 100 kilograms of textile waste, undertook plantation activities, and encouraged employees to adopt environmentally responsible practices
Targeting deadly drug-resistant acinetobacter infections
Independent DSMB recommends continuation of Masupirdine without modifications as enrollment reaches 88% in global trial
Subscribe To Our Newsletter & Stay Updated
